SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Phillip J. Gray, Chun Chieh Lin, Ahmedin Jemal, William U. Shipley, Stacey A. Fedewa, Adam S. Kibel, Jonathan E. Rosenberg, Ashish M. Kamat, Katherine S. Virgo, Michael L. Blute, Anthony L. Zietman, Jason A. Efstathiou, Clinical–Pathologic Stage Discrepancy in Bladder Cancer Patients Treated With Radical Cystectomy: Results From the National Cancer Data Base, International Journal of Radiation Oncology*Biology*Physics, 2014, 88, 5, 1048

    CrossRef

  2. 2
    Fausto Petrelli, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Ivano Vavassori, Sandro Barni, Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis, European Urology, 2014, 65, 2, 350

    CrossRef

  3. 3
    J. Alfred Witjes, Eva Compérat, Nigel C. Cowan, Maria De Santis, Georgios Gakis, Thierry Lebret, Maria J. Ribal, Antoine G. Van der Heijden, Amir Sherif, EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines, European Urology, 2014, 65, 4, 778

    CrossRef

  4. 4
    Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer, Medical Oncology, 2014, 31, 5

    CrossRef

  5. 5
    Hugh J. Lavery, Kristian D. Stensland, Guenter Niegisch, Peter Albers, Michael J. Droller, Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful Surrogate, The Journal of Urology, 2014, 191, 4, 898

    CrossRef

  6. 6
    Petros D. Grivas, Maha Hussain, Khaled Hafez, Stephanie Daignault-Newton, David Wood, Cheryl T. Lee, Alon Weizer, James E. Montie, Brent Hollenbeck, Jeffrey S. Montgomery, Ajjai Alva, David C. Smith, A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder, Urology, 2013, 82, 1, 111

    CrossRef

  7. 7
    Nobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, Masahiko Nezu, Kuniaki Itoh, Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer, Asia-Pacific Journal of Clinical Oncology, 2013, 9, 4
  8. 8
    Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura, Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study, International Journal of Clinical Oncology, 2013, 18, 4, 724

    CrossRef

  9. 9
    Cora N. Sternberg, Joaquim Bellmunt, Guru Sonpavde, Arlene O. Siefker-Radtke, Walter M. Stadler, Dean F. Bajorin, Robert Dreicer, Daniel J. George, Matthew I. Milowsky, Dan Theodorescu, David J. Vaughn, Matthew D. Galsky, Mark S. Soloway, David I. Quinn, ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings, European Urology, 2013, 63, 1, 58

    CrossRef

  10. 10
    Kiranpreet K. Khurana, Jorge A. Garcia, Rahul D. Tendulkar, Andrew J. Stephenson, Multidisciplinary Management of Patients with Localized Bladder Cancer, Surgical Oncology Clinics of North America, 2013, 22, 2, 357

    CrossRef

  11. 11
    Damien Pouessel, Pierre Mongiat-Artus, Stéphane Culine, Neoadjuvant chemotherapy in muscle-invasive bladder cancer: Ready for prime time?, Critical Reviews in Oncology/Hematology, 2013, 85, 3, 288

    CrossRef

  12. 12
    Adrian S. Fairey, Siamak Daneshmand, David Quinn, Tanya Dorff, Ryan Dorin, Gary Lieskovsky, Anne Schuckman, Jie Cai, Gus Miranda, Eila C. Skinner, Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California, Urologic Oncology: Seminars and Original Investigations, 2013, 31, 8, 1737

    CrossRef

  13. 13
    K. Iwasaki, W. Obara, Y. Kato, R. Takata, S. Tanji, T. Fujioka, Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer, Japanese Journal of Clinical Oncology, 2013, 43, 2, 193

    CrossRef

  14. 14
    Franklin C. Lee, William Harris, Heather H. Cheng, Jaideep Shenoi, Song Zhao, Junfeng Wang, Thomas Champion, Jason Izard, John L. Gore, Michael Porter, Evan Y. Yu, Jonathan L. Wright, Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer, Advances in Urology, 2013, 2013, 1

    CrossRef

  15. 15
    Bertram E. Yuh, Nora Ruel, Timothy G. Wilson, Nicholas Vogelzang, Sumanta K. Pal, Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer, The Journal of Urology, 2013, 189, 5, 1682

    CrossRef

  16. You have free access to this content16
    Mun Sem Liew, Arun Azad, Ali Tafreshi, Renu Eapen, Damien Bolton, Ian D. Davis, Shomik Sengupta, USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer, BJU International, 2013, 112,
  17. 17
    Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. Galsky, Noah M. Hahn, Seth P. Lerner, Malcolm Mason, Thomas Powles, Cora N. Sternberg, Guru Sonpavde, A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer, European Urology, 2012, 62, 3, 523

    CrossRef

  18. 18
    Christopher Blick, Peter Hall, Thinn Pwint, Faisal Al-Terkait, Jeremy Crew, Thomas Powles, Valentine Macaulay, Nicholas Munro, David Douglas, Neviana Kilbey, Andrew Protheroe, John D. Chester, Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder, Cancer, 2012, 118, 16
  19. 19
    N. Houédé, P. Beuzeboc, S. Culine, M. Soulié, C. Pfister, Chimiothérapie périopératoire des carcinomes urothéliaux infiltrants de vessie de stade localisé. Une revue de la littérature du groupe vessie du CC-AFU, Progrès en Urologie, 2012, 22, 3, 139

    CrossRef

  20. 20
    Ajjai S. Alva, Christopher T. Tallman, Chang He, Maha H. Hussain, Khaled Hafez, James E. Montie, David C. Smith, Alon Z. Weizer, David Wood, Cheryl T. Lee, Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer, Cancer, 2012, 118, 1
  21. You have free access to this content21
    Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, Naokazu Ibuki, Hayahito Nomi, Kazuhiro Yamamoto, Yoshihumi Narumi, Takanobu Ubai, Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: Development of novel bladder preservation approach, Osaka Medical College regimen, International Journal of Urology, 2012, 19, 1
  22. 22
    Guru Sonpavde, Cora N. Sternberg, Neoadjuvant Chemotherapy for Invasive Bladder Cancer, Current Urology Reports, 2012, 13, 2, 136

    CrossRef

  23. 23
    Emil Scosyrev, Edward M. Messing, Edwin van Wijngaarden, Derick R. Peterson, Deepak Sahasrabudhe, Dragan Golijanin, Susan G. Fisher, Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder, Cancer, 2012, 118, 1
  24. 24
    Mun Sem LIEW, George AU-YEUNG, Ian D. DAVIS, Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 1
  25. 25
    Andrea B. Apolo, Herbert Barton Grossman, Dean Bajorin, Gary Steinberg, Ashish M. Kamat, Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting, Urologic Oncology: Seminars and Original Investigations, 2012, 30, 6, 772

    CrossRef

  26. 26
    Olga Yeshchina, Gina M. Badalato, Matthew S. Wosnitzer, Gregory Hruby, Arindam RoyChoudhury, Mitchell C. Benson, Daniel P. Petrylak, James M. McKiernan, Relative Efficacy of Perioperative Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urothelial Carcinoma of the Bladder, Urology, 2012, 79, 2, 384

    CrossRef

  27. 27
    Sumanta K. Pal, Nora H. Ruel, Timothy G. Wilson, Bertram E. Yuh, Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer, Clinical Genitourinary Cancer, 2012, 10, 4, 246

    CrossRef

  28. 28
    Amber M. D’Souza, Kamal S. Pohar, Tahir Arif, Susan Geyer, Debra L. Zynger, Retrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy, Virchows Archiv, 2012, 461, 4, 467

    CrossRef

  29. 29
    A. Stenzl, N.C. Cowan, M. De Santis, M.A. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes, Tratamiento del cáncer de vejiga con invasión muscular y metastásico: actualización de la Guía Clínica de la EAU, Actas Urológicas Españolas, 2012, 36, 8, 449

    CrossRef

  30. 30
    A. Stenzl, N.C. Cowan, M. De Santis, M.A. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes, Treatment of muscle-invasive and metastatic bladder cancer: Update of the EAU guidelines, Actas Urológicas Españolas (English Edition), 2012, 36, 8, 449

    CrossRef

  31. 31
    Carmel Pezaro, Mun Sem Liew, Ian D Davis, Urothelial cancers: using biology to improve outcomes, Expert Review of Anticancer Therapy, 2012, 12, 1, 87

    CrossRef

  32. 32
    C.-H. Ohlmann, M. Stöckle, Wann soll eine systemische Chemotherapie beim Harnblasenkarzinom eingesetzt werden?, Der Urologe, 2012, 51, 3, 325

    CrossRef

  33. 33
    Pirus Ghadjar, Fiona C. Burkhard, Oliver Gautschi, George N. Thalmann, Urs E. Studer, Induction chemotherapy for unresectable urothelial carcinoma of the bladder, BJU International, 2011, 107, 6
  34. 34
    Andrew H. Feifer, Jennifer M. Taylor, Tatum V. Tarin, Harry W. Herr, Maximizing Cure for Muscle-Invasive Bladder Cancer: Integration of Surgery and Chemotherapy, European Urology, 2011, 59, 6, 978

    CrossRef

  35. 35
    Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, Markus A. Kuczyk, Axel S. Merseburger, Maria José Ribal, Amir Sherif, J. Alfred Witjes, Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines, European Urology, 2011, 59, 6, 1009

    CrossRef

  36. 36
    Guru Sonpavde, Cora N. Sternberg, Neoadjuvant systemic therapy for urological malignancies, BJU International, 2010, 106, 1
  37. 37
    Nathan Lawrentschuk, Renzo Colombo, Oliver W. Hakenberg, Seth P. Lerner, Wiking Månsson, Arthur Sagalowsky, Manfred P. Wirth, Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer, European Urology, 2010, 57, 6, 983

    CrossRef

  38. 38
    Faysal A Yafi, Wassim Kassouf, Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?, Expert Review of Anticancer Therapy, 2009, 9, 6, 747

    CrossRef

  39. 39
    Neeraj Agarwal, Maha Hussain, Management of Bladder Cancer, Drugs, 2009, 69, 9, 1173

    CrossRef